Holen Sie sich die Stockscreener-App
187.86
2.87%
5.24
Schlusskurs vom Vortag:
$182.62
Offen:
$184.99
24-Stunden-Volumen:
291.52K
Relative Volume:
1.13
Marktkapitalisierung:
$5.41B
Einnahmen:
$241.52M
Nettoeinkommen (Verlust:
$52.37M
KGV:
105.54
EPS:
1.78
Netto-Cashflow:
$58.06M
1W Leistung:
+22.59%
1M Leistung:
+23.96%
6M Leistung:
-6.83%
1J Leistung:
+73.93%
1-Tages-Spanne:
$184.12
$189.19
1-Wochen-Bereich:
$148.00
$190.00
52-Wochen-Spanne:
$107.50
$219.34
Krystal Biotech Inc Stock (KRYS) Company Profile
Firmenname
Krystal Biotech Inc
Sektor
Branche
Telefon
(412) 586-5830
Adresse
2100 WHARTON STREET, PITTSBURGH, PA
Vergleichen Sie KRYS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KRYS
Krystal Biotech Inc
|
187.86 | 5.41B | 241.52M | 52.37M | 58.06M | 1.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.24 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
700.33 | 76.56B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
644.48 | 39.16B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
250.59 | 32.44B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
120.01 | 28.77B | 3.30B | -501.07M | 1.03B | -2.1146 |
Krystal Biotech Inc Stock (KRYS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-06 | Herabstufung | Citigroup | Buy → Neutral |
| 2023-11-20 | Eingeleitet | Goldman | Buy |
| 2023-10-24 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-10-12 | Eingeleitet | Citigroup | Buy |
| 2023-09-07 | Eingeleitet | Berenberg | Buy |
| 2023-04-18 | Eingeleitet | Stifel | Buy |
| 2023-02-28 | Hochstufung | Goldman | Neutral → Buy |
| 2022-08-25 | Herabstufung | Goldman | Buy → Neutral |
| 2022-01-18 | Eingeleitet | BofA Securities | Buy |
| 2021-07-20 | Hochstufung | Goldman | Neutral → Buy |
| 2020-09-18 | Eingeleitet | B. Riley FBR | Buy |
| 2020-06-04 | Eingeleitet | Evercore ISI | Outperform |
| 2019-09-24 | Eingeleitet | Goldman | Neutral |
| 2019-08-06 | Bestätigt | H.C. Wainwright | Buy |
| 2019-06-24 | Bestätigt | Chardan Capital Markets | Buy |
| 2019-06-24 | Bestätigt | H.C. Wainwright | Buy |
| 2019-05-30 | Eingeleitet | Guggenheim | Buy |
| 2018-09-11 | Eingeleitet | Cantor Fitzgerald | Overweight |
Alle ansehen
Krystal Biotech Inc Aktie (KRYS) Neueste Nachrichten
William Blair Comments on Krystal Biotech Q1 Earnings - Defense World
Krystal Biotech projects EU and Japan launches for VYJUVEK in 2025, targeting $1B global peak sales - MSN
Krystal Biotech (KRYS) Upgraded to Buy: Here's What You Should Know - MSN
Krystal Biotech (NASDAQ:KRYS) Receives "Overweight" Rating from Cantor Fitzgerald - MarketBeat
Chardan Capital Forecasts Strong Price Appreciation for Krystal Biotech (NASDAQ:KRYS) Stock - MarketBeat
Krystal Biotech Soars As Q4 Earnings Put Blockbuster Commercialization In Focus (KRYS) - Seeking Alpha
Krystal Biotech (NASDAQ:KRYS) Trading 7.1% Higher on Analyst Upgrade - Defense World
Krystal Biotech, Inc. (NASDAQ:KRYS) Stock Holdings Cut by Allspring Global Investments Holdings LLC - Defense World
Vontobel Holding Ltd. Decreases Stake in Krystal Biotech, Inc. (NASDAQ:KRYS) - Defense World
Krystal Biotech Q4 Earnings Beat Estimates, Sales Miss, Stock Up - MSN
Short Interest in Krystal Biotech, Inc. (NASDAQ:KRYS) Declines By 7.4% - MarketBeat
Krystal Biotech Earnings Call: Optimism Amid Challenges - TipRanks
H.C. Wainwright maintains Buy on Krystal stock, $221 target By Investing.com - Investing.com South Africa
A Glimpse Into The Expert Outlook On Krystal Biotech Through 9 Analysts - Benzinga
Krystal Biotech (NASDAQ:KRYS) Given "Buy" Rating at HC Wainwright - MarketBeat
Krystal Biotech (NASDAQ:KRYS) Shares Gap DownWhat's Next? - MarketBeat
Krystal Biotech (NASDAQ:KRYS) Posts Quarterly Earnings Results, Beats Estimates By $0.23 EPS - MarketBeat
H.C. Wainwright maintains Buy on Krystal stock, $221 target - Investing.com
Krystal Biotech, Inc. (NASDAQ:KRYS) Q4 2024 Earnings Call Transcript - Insider Monkey
3 US Growth Companies With High Insider Ownership Expecting Up To 68% Earnings Growth - Simply Wall St
TimesSquare Capital Management LLC Purchases 44,646 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS) - MarketBeat
Krystal Biotech’s (KRYS) “Buy” Rating Reaffirmed at HC Wainwright - Defense World
Krystal Biotech, Inc. (NASDAQ:KRYS) Receives Average Recommendation of "Buy" from Analysts - MarketBeat
Krystal Biotech (KRYS) Expected to Announce Earnings on Wednesday - MarketBeat
Krystal Biotech Inc (KRYS) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic ... - Yahoo Finance
Krystal Biotech Reports Robust 2024 Financial Growth - TipRanks
Krystal Biotech shares rise 20% following earnings call - The Business Journals
Krystal Biotech earnings beat by $0.31, revenue fell short of estimates - Investing.com Canada
High Growth Tech Stocks in United States to Watch - Simply Wall St
Earnings call transcript: Krystal Biotech Q4 2024 beats EPS forecasts By Investing.com - Investing.com Nigeria
Earnings call transcript: Krystal Biotech Q4 2024 beats EPS forecasts - Investing.com
Krystal Biotech rises after quarterly revenue beat - TradingView
Krystal Biotech Inc (KRYS) Q4 2024 Earnings Report Preview: What to Look For - GuruFocus.com
Krystal Biotech Q4 Net Income, Revenue Rise -February 19, 2025 at 07:41 am EST - Marketscreener.com
Krystal Biotech, Inc. SEC 10-K Report - TradingView
Krystal Biotech Announces Fourth Quarter and Full Year 2024 Financial and Operating Results - The Manila Times
Krystal Biotech reports Q4 EPS $1.52, consensus $1.85 - TipRanks
Krystal Biotech Reports 116% Revenue Increase in Q4 2024 and 473% Growth for Full Year, Secures Full Sanctioning for KB407 Phase 1 Protocol - Nasdaq
Earnings Flash (KRYS) Krystal Biotech Posts Q4 Adjusted EPS $1.52, vs. FactSet Est of $1.20 - Marketscreener.com
Krystal Biotech Announces Fourth Quarter and Full Year 2024 Financial and Operating Results - GlobeNewswire Inc.
Krystal Biotech, Inc. (NASDAQ:KRYS) Short Interest Down 7.4% in January - Defense World
Entropy Technologies LP Buys New Holdings in Krystal Biotech, Inc. (NASDAQ:KRYS) - MarketBeat
Krystal Biotech, Inc. (NASDAQ:KRYS) Stock Position Decreased by Mirae Asset Global Investments Co. Ltd. - Defense World
Yousif Capital Management LLC Lowers Stock Holdings in Krystal Biotech, Inc. (NASDAQ:KRYS) - Defense World
abrdn plc Buys 13,979 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS) - MarketBeat
Looking Into Krystal Biotech's Recent Short Interest - Benzinga
Krystal Biotech, Inc. (NASDAQ:KRYS) Stock Position Lowered by Jennison Associates LLC - MarketBeat
KBC Group NV Purchases 297 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS) - Defense World
Finanzdaten der Krystal Biotech Inc-Aktie (KRYS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.27%
3.05%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):